Skip to main content
Premium Trial:

Request an Annual Quote

ABI Balks, and SurroMed Taps Callida to Share $7.6M Grant to Build HTP Genotyping System

NEW YORK, Oct. 1 - SurroMed and Callida Genomics will share a $7.6 million grant from the US government to develop a universal high-throughput genotyping system.

 

The partners said the money, awarded by the National Institute of Standards and Technology's Advanced Technology Program, will help them develop a system that can score more than 100,000 SNPs per patient using a solution-array approach.

 

Over the next three years, SurroMed, which will receive $4.4 million, will bring to the table its Nanobarcode particle technology. Hyseq subsidiary Callida, which will pocket $3.2 million, will amplify DNA and identify and read SNPs, the companies said. NIST awards require each company to match its portion.

 

A SurroMed spokesman said the award, in October 2001, was originally slated to go to his company and Applied Biosystems. But ABI balked out, leaving SurroMed scrambling for a new partner. "We identified Callida, and here we are," said the spokesman, August Moretti.

 

Click here for more information.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.